Literature DB >> 11852181

Identification of a novel transcript of X25, the human gene involved in Friedreich ataxia.

Luigi Pianese1, Angela Tammaro, Mimmo Turano, Irene De Biase, Antonella Monticelli, Sergio Cocozza.   

Abstract

Friedreich ataxia (FRDA) is caused by a GAA triplet expansion in the first intron of the X25 gene. The X25 gene encodes a 210-amino acid protein, frataxin (A isoform). Here, we report the identification of a new transcript of the X25 gene generated by alternative splicing by the use of a second donor splice site in the intron 4. Full-length cDNA transcript sequence revealed an insertion of 8 bp between 4 and 5a exon sequence. This event leads to a frameshift in the mRNA reading frame and introduces a new stop codon at position 589. Therefore, this X25 transcript variant may encode a 196-amino acid protein, the A1 isoform, that structurally differs from the main A isoform of 210 amino acids after residue 160. In all human tissues analyzed, reverse transcription-polymerase chain reaction experiments demonstrated that the A1 isoform was expressed at low levels compared with the predominant A isoform. No difference in A and A1 isoform expression rate was detected between FRDA patients and normal controls. We did not find an A1 like splice variant in rodents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11852181     DOI: 10.1016/s0304-3940(02)00048-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

Review 1.  Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities.

Authors:  Renata Santos; Sophie Lefevre; Dominika Sliwa; Alexandra Seguin; Jean-Michel Camadro; Emmanuel Lesuisse
Journal:  Antioxid Redox Signal       Date:  2010-09-01       Impact factor: 8.401

2.  Conservation of human alternative splice events in mouse.

Authors:  T A Thanaraj; Francis Clark; Juha Muilu
Journal:  Nucleic Acids Res       Date:  2003-05-15       Impact factor: 16.971

3.  Frataxin mRNA isoforms in FRDA patients and normal subjects: effect of tocotrienol supplementation.

Authors:  Provvidenza Maria Abruzzo; Marina Marini; Alessandra Bolotta; Gemma Malisardi; Stefano Manfredini; Alessandro Ghezzo; Antonella Pini; Gianluca Tasco; Rita Casadio
Journal:  Biomed Res Int       Date:  2013-09-23       Impact factor: 3.411

Review 4.  Analysis of Putative Epigenetic Regulatory Elements in the FXN Genomic Locus.

Authors:  Iván Fernández-Frías; Sara Pérez-Luz; Javier Díaz-Nido
Journal:  Int J Mol Sci       Date:  2020-05-12       Impact factor: 5.923

5.  Evaluation of antibodies for western blot analysis of frataxin protein isoforms.

Authors:  Liwei Weng; Qingqing Wang; Sixiang Yu; Xiaolu Yang; David R Lynch; Clementina Mesaros; Ian A Blair
Journal:  J Immunol Methods       Date:  2019-07-04       Impact factor: 2.303

Review 6.  Recent Advances in the Elucidation of Frataxin Biochemical Function Open Novel Perspectives for the Treatment of Friedreich's Ataxia.

Authors:  Beata Monfort; Kristian Want; Sylvain Gervason; Benoit D'Autréaux
Journal:  Front Neurosci       Date:  2022-03-02       Impact factor: 4.677

7.  Characterization of a new N-terminally acetylated extra-mitochondrial isoform of frataxin in human erythrocytes.

Authors:  Lili Guo; Qingqing Wang; Liwei Weng; Lauren A Hauser; Cassandra J Strawser; Clementina Mesaros; David R Lynch; Ian A Blair
Journal:  Sci Rep       Date:  2018-11-19       Impact factor: 4.379

8.  Effect of Mitochondrial and Cytosolic FXN Isoform Expression on Mitochondrial Dynamics and Metabolism.

Authors:  Mauro Agrò; Javier Díaz-Nido
Journal:  Int J Mol Sci       Date:  2020-11-04       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.